GeneTether Therapeutics Inc. (GTTX.CN) Research

GeneTether Therapeutics Inc. (GTTX.CN) is a biotechnology firm specializing in genetic medicines. Its primary focus is the advancement of gene-editing therapies, aiming to significantly boost the effectiveness of current genomic modification techniques. The company's pipeline is dedicated to engineering genetic treatments for individuals suffering from rare, single-gene disorders affecting the kidneys and skin. Established in 2018, GeneTether Therapeutics Inc. is headquartered in Kelowna, Canada.

Market snapshot

Symbol
GTTX.CN
Price
$0.12
Day change
0.00%
Market cap
$3.3M
P/E ratio
-5.71x
52-week range
0.0-0.12
Sector
Healthcare
Industry
Biotechnology

Peer companies

  • Asep Medical Holdings Inc (ASEP.CN)
  • Awakn Life Sciences Corp. (AWKN.NE)
  • The BC Bud Corporation (BCBC.CN)
  • Bhang Inc. (BHNG.CN)
  • Heritage Cannabis Holdings Corp. (CANN.CN)
  • Clearmind Medicine Inc. (CMND.CN)
  • 4Front Ventures Corp. (FFNT.CN)
  • MYND Life Sciences Inc. (MYND.CN)

Open GeneTether Therapeutics Inc. (GTTX.CN) in Thesis for live fundamentals, charts, options context, and portfolio-aware Copilot follow-ups.